Literature DB >> 2844455

Natural killing of fibroblasts infected with low-passage clinical isolates of human cytomegalovirus.

S Bandyopadhyay1, S H Oh, S Michelson, D S Miller, J L Virelizier, S E Starr.   

Abstract

Fibroblasts infected with most low-passage clinical isolates of human cytomegalovirus (CMV) were as susceptible to lysis by human natural killer (NK) cells as high passage AD-169-infected fibroblasts. NK lysis occurred despite the absence of detectable CMV-specific late membrane antigen(s) on the majority of the target cells infected with most of the low passage strains. The magnitude of NK lysis of different CMV-infected target cells did not correlate with their ability to induce IFN-alpha. NK cell-mediated lysis of cells infected with low-passage clinical isolates of CMV required both NK cells and HLA-DR+ accessory cells, as previously shown for AD-169-infected target cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844455      PMCID: PMC1541462     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

Review 1.  Cytomegalovirus.

Authors:  S E Starr
Journal:  Pediatr Clin North Am       Date:  1979-05       Impact factor: 3.278

2.  Anti-complement immunofluorescence test for antibodies to human cytomegalovirus.

Authors:  J D Kettering; N J Schmidt; D Gallo; E H Lennette
Journal:  J Clin Microbiol       Date:  1977-12       Impact factor: 5.948

3.  Pronounced antiviral activity of human interferon on bovine and porcine cells.

Authors:  I Gresser; M T Bandu; D Brouty-boye; M Tovey
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

4.  Cytomegalovirus-specific cytotoxicity mediated by non-T lymphocytes from peripheral blood of normal volunteers.

Authors:  N Kirmani; R K Ginn; K K Mittal; J F Manischewitz; G V Quinnan
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

5.  Monoclonal antibodies that detect differentiation surface antigens on human myelomonocytic cells.

Authors:  B Perussia; G Trinchieri; D Lebman; J Jankiewicz; B Lange; G Rovera
Journal:  Blood       Date:  1982-02       Impact factor: 22.113

6.  Candidate cytomegalovirus strain for human vaccination.

Authors:  S A Plotkin; T Furukawa; N Zygraich; C Huygelen
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

7.  Pretreatment of plastic Petri dishes with fetal calf serum. A simple method for macrophage isolation.

Authors:  K Kumagai; K Itoh; S Hinuma; M Tada
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

8.  Lymphocyte blastogenesis and interferon production in adult human leukocyte cultures stimulated with cytomegalovirus antigens.

Authors:  S E Starr; B Dalton; T Garrabrant; K Paucker; S A Plotkin
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

9.  Natural killing of cytomegalovirus-infected fibroblasts by human mononuclear leucocytes.

Authors:  S E Starr; T Garrabrant
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

10.  Gamma interferon production by combinations of human peripheral blood lymphocytes, monocytes, and cultured macrophages.

Authors:  R D Arbeit; P L Leary; M J Levin
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

View more
  4 in total

1.  Dendritic cells and IFN-alpha-producing cells are two functionally distinct non-B, non-monocytic HLA-DR+ cell subsets in human peripheral blood.

Authors:  J Chehimi; S E Starr; H Kawashima; D S Miller; G Trinchieri; B Perussia; S Bandyopadhyay
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

2.  Impairment of natural killer cell activity in Indian kala-azar: restoration of activity by interleukin 2 but not by alpha or gamma interferon.

Authors:  P P Manna; D Bharadwaj; S Bhattacharya; G Chakrabarti; D Basu; K K Mallik; S Bandyopadhyay
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

3.  Natural killer cell-mediated lysis of T cell lines chronically infected with HIV-1.

Authors:  S Bandyopadhyay; U Ziegner; D E Campbell; D S Miller; J A Hoxie; S E Starr
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

Review 4.  Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19.

Authors:  Madhan Jeyaraman; Sathish Muthu; Asawari Bapat; Rashmi Jain; E S Sushmitha; Arun Gulati; Talagavadi Channaiah Anudeep; Shirodkar Jaswandi Dilip; Niraj Kumar Jha; Dhruv Kumar; Kavindra Kumar Kesari; Shreesh Ojha; Sunny Dholpuria; Gaurav Gupta; Harish Dureja; Dinesh Kumar Chellappan; Sachin Kumar Singh; Kamal Dua; Saurabh Kumar Jha
Journal:  Heliyon       Date:  2021-07-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.